Guernsey

Reimbursed Care Access

Guernsey (the Bailiwick) retains a strict controlled‑drugs legal framework derived from the Misuse of Drugs (Bailiwick of Guernsey) Law, with possession, supply and importation of most classical psychedelics criminalised and active policing of imports. Medical access to psychedelic medicines is extremely limited: standard anaesthetic/acute uses of ketamine remain available within licensed health services, while novel psychedelic therapies (e.g., psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, mescaline, 2C‑X) are only accessible through approved clinical research or not at all. There is no evidence of routine public reimbursement for licensed psychedelic psychiatric medicines (e.g., SPRAVATO/esketamine) in Guernsey; prescribing and availability are controlled locally under the Bailiwick medicines regime and most specialist treatments are pursued via private prescription pathways or off‑island referral.